The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
Hualong Xiong(Xiamen University), Ningshao Xia(Xiamen University), Liqin Liu(Xinjiang Agricultural University), Ruoyao Qi(Xiamen University), Jian Ma(Central South University), Rao Fu(Northwest University), Qingbing Zheng(Xiamen University), Yang Huang(Xiamen University), Mingxi Yue(Xiamen University), Siping Yan(Xiamen University), Yi Guan(Tianjin Medical University Eye Hospital), Hai Yu(Xiamen University), Lunzhi Yuan(Xiamen University), Zizheng Zheng(Xiamen University), Yuhe Zhu(Xiamen University), Quan Yuan(Xuzhou Medical College), Tingting Li(Peking University First Hospital), Jun Zhang(Army Medical University), Min Wei, Yizhen Wang(Xi'an University of Science and Technology), Ming Zhou(Xiamen University), Shaowei Li(Xiamen University), Hui Sun(Heilongjiang University of Chinese Medicine), Yingbin Wang(First Affiliated Hospital of Gannan Medical University), Yue Ma(Xiamen University), Siling Wang(Xiamen University), Jinlei Zhang(Suzhou University of Science and Technology), Yao Jiang(Suizhou Central Hospital), Tianying Zhang(Guangdong Medical College), Tong Cheng(Xiamen University), Yangtao Wu(Xiamen University)
Cited by 28
Related Papers
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|Science|2013|1.2k
Oseltamivir Resistance during Treatment of Influenza A (H5N1) Infection
|New England Journal of Medicine|2005|900
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.
|Journal of Clinical Investigation|1997|550